2007
DOI: 10.1016/j.amepre.2007.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Changing Smokeless Tobacco Products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
95
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 97 publications
(95 citation statements)
references
References 66 publications
0
95
0
Order By: Relevance
“…It is marketed (www.dissolvabletobacco.com) as having "no smoke or tar" and having "the lowest level of TSNAs [tobacco-specific nitrosamines] of any smokeless tobacco product marketed in the US," a finding based on independent evaluation (Hatsukami, Ebbert, Feuer, Stepanov, & Hecht, 2007;Stepanov, Jensen, Hatsukami, & Hecht, 2006). It was developed to "give adult smokers a smoke/tar free alternative that is effective and satisfying" and to "create a tobacco product with the lowest levels of the leading toxins."…”
Section: Ariva and Stonewallmentioning
confidence: 99%
“…It is marketed (www.dissolvabletobacco.com) as having "no smoke or tar" and having "the lowest level of TSNAs [tobacco-specific nitrosamines] of any smokeless tobacco product marketed in the US," a finding based on independent evaluation (Hatsukami, Ebbert, Feuer, Stepanov, & Hecht, 2007;Stepanov, Jensen, Hatsukami, & Hecht, 2006). It was developed to "give adult smokers a smoke/tar free alternative that is effective and satisfying" and to "create a tobacco product with the lowest levels of the leading toxins."…”
Section: Ariva and Stonewallmentioning
confidence: 99%
“…The information on (S)-NNN content in smokeless tobacco products is of particular interest due to the recently discovered oral carcinogenicity of this enantiomer, as well as the increasing sales of moist snuff in the United States (Balbo et al, 2012;Nelson et al, 2006;U.S. Federal Trade Commission, 2007), and the introduction of novel smokeless tobacco products that are marketed to smokers as a temporary or permanent substitute for smoking (Hatsukami, Ebbert, Feuer, Stepanov, & Hecht, 2007;Rogers, Biener, & Clark, 2010). Moreover, there is no information available on the enantiomeric composition of NNN in cigarette smoke.…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, the Institute of Medicine (IOM) warns that availability of other tobacco products may have a net negative impact on public health since smokers might delay or refrain from quitting, former smokers may be drawn back to tobacco use, and nonsmokers might be encouraged to start using tobacco (IOM, 2012). Therefore, evaluating the net impact of these other tobacco products (hereafter referred to as unconventional tobacco products) on public health is an important and complex question (Bombard, Rock, Pederson, & Asman, 2008;Hatsukami et al, 2002;Hatsukami, Ebbert, Feuer, Stepanov, & Hecht, 2007;O'Connor, 2012;Shiffman et al, 2002).…”
Section: Introductionmentioning
confidence: 99%